ADPKD current management and ongoing trials-Reference-Cited by-同舟云学术

ADPKD current management and ongoing trials

Published:2019-12-18 Issue:2 Volume:33 Page:223-237
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Testa Francesca,Magistroni Riccardo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-019-00679-y.pdf

Reference85 articles.

1. Pippias M, Kramer A, Noordzij M et al (2017) The european renal association – european dialysis and transplant association registry annual report 2014: a summary. Clin Kidney J 10:154–169

2. Spithoven EM, Kramer A, Meijer E et al (2014) Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival–an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant 29(4):iv15–iv25

3. Porath B, Gainullin VG, Cornec-Le Gall E et al (2016) Mutations in GANAB, encoding the glucosidase iialpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 98:1193–1207

4. Cornec-Le Gall E, Olson RJ, Besse W et al (2018) Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease. Am J Hum Genet 102:832–844

5. Solazzo A, Testa F, Giovanella S et al (2018) The prevalence of autosomal dominant polycystic kidney disease (ADPKD): a meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition. PLoS One 13:e0190430

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease – A Randomized Control Trial;Indian Journal of Nephrology;2024-08-29

2. Oral delivery of nanomedicine for genetic kidney disease;PNAS Nexus;2024-04-30

3. Treatment for patients with autosomal dominant polycystic kidney disease in the chronic kidney disease without kidney replacement therapy in real-world clinical practice: a descriptive retrospective cohort study;Annals of Clinical Epidemiology;2024

4. Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management;Seminars in Nephrology;2023-11

5. Metabolism-based approaches for autosomal dominant polycystic kidney disease;Frontiers in Molecular Biosciences;2023-02-16